Abbonarsi

A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos) - 23/08/11

Doi : 10.1016/j.gie.2008.02.050 
Stefan Seewald, MD , Tiing Leong Ang, MD, Hiroo Imazu, MD, Mazen Naga, MD, Salem Omar, MD, Stefan Groth, MD, Uwe Seitz, MD, Yan Zhong, MD, Frank Thonke, MD, Nib Soehendra, MD
Current affiliations: Department of Interdisciplinary Endoscopy (S. S., T. L. A., H. I., S. O., S. G., U. S., Y. Z., F. T., N. S.), University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Department of Internal Medicine (M. N.), University of Cairo, Cairo, Egypt 

Reprint requests: Stefan Seewald, MD, Department of Interdisciplinary Endoscopy, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Hamburg, Germany, Cairo, Egypt

Abstract

Background

N-butyl-2-cyanoacrylate has been successfully used for the treatment of bleeding from gastric fundal varices (FV). However, significant rebleeding rates and serious complications including embolism have been reported.

Objective

Our purpose was to analyze the safety and efficacy of N-butyl-2-cyanoacrylate for FV bleeding by using a standardized injection technique and regimen.

Design

Retrospective.

Setting

Two tertiary referral centers.

Patients

A total of 131 patients (91 men/40 women) with FV underwent obliteration with N-butyl-2-cyanoacrylate by a standardized technique and regimen.

Interventions

(1) Dilution of 0.5 mL of N-butyl-2-cyanoacrylate with 0.8 mL of Lipiodol, (2) limiting the volume of mixture to 1.0 mL per injection to minimize the risk of embolism, (3) repeating intravariceal injections of 1.0 mL each until hemostasis was achieved, (4) obliteration of all tributaries of the FV, (5) repeat endoscopy 4 days after the initial treatment to confirm complete obliteration of all visible varices and repeat N-butyl-2-cyanoacrylate injection if necessary to accomplish complete obliteration.

Main Outcome Measurements

Immediate hemostasis rate, early rebleeding rate, bleeding-related mortality rate, procedure-related complications, long-term cumulative rebleeding-free rate, and cumulative survival rate.

Results

Initial hemostasis and variceal obliteration were achieved in all patients. The mean number of sessions was 1 (range 1-3). The mean total volume of glue mixture used was 4.0 mL (range 1-13 mL). There was no occurrence of early FV rebleeding, procedure-related complications, or bleeding-related death. The cumulative rebleeding-free rate at 1, 3, and 5 years was 94.5%, 89.3%, and 82.9%, respectively.

Conclusion

Obliteration of bleeding FV with N-butyl-2-cyanoacrylate is safe and effective with use of a standardized injection technique and regimen.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : B-RTO, EIS, B-RTP-EIS, EV, EVL, FV, GOV, GRS, GV, IGV, HVPG, TIPS


Mappa


 Presented at Digestive Disease Week, May 2005, Chicago, Illinois, USA (Gastrointest Endosc 2005;61:AB91).
 See CME section; p. 532.


© 2008  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 68 - N° 3

P. 447-454 - settembre 2008 Ritorno al numero
Articolo precedente Articolo precedente
  • The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage
  • Samuel Herrera, Josep M. Bordas, Josep Llach, Angels Ginès, Maria Pellisé, Glòria Fernández-Esparrach, Fernando Mondelo, Alfredo Mata, Andres Cárdenas, Antoni Castells
| Articolo seguente Articolo seguente
  • Endoscopic transpapillary gallbladder drainage in patients with acute cholecystitis in whom percutaneous transhepatic approach is contraindicated or anatomically impossible (with video)
  • Takao Itoi, Atsushi Sofuni, Fumihide Itokawa, Takayoshi Tsuchiya, Toshio Kurihara, Kentaro Ishii, Shujiro Tsuji, Nobuhito Ikeuchi, Sakiko Tsukamoto, Mani Takeuchi, Takashi Kawai, Fuminori Moriyasu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.